Jaslok Hospital Partners with AnginaX AI to Launch Maharashtra’s First AI-Powered Heart Disease Prevention Model

Jaslok Hospital Partners with AnginaX AI to Launch Maharashtra’s First AI-Powered Heart Disease Prevention Model
Published on
3 min read

In a groundbreaking step towards redefining cardiovascular care in India, Jaslok Hospital & Research Centre has partnered with AnginaX AI, the country’s first licensed AI Doctor Assistant in cardiology, to unveil Maharashtra’s first operational AI-driven heart disease prevention model.

This pioneering collaboration places Jaslok Hospital at the forefront of India's transition from reactive cardiac care to proactive, AI-powered prevention. By integrating AnginaX AI into its outpatient departments (OPDs), Jaslok empowers its clinicians to evaluate a patient’s cardiovascular risk within seconds, using structured, science-backed assessments—even before symptoms appear. These assessments come with personalized lifestyle recommendations and treatment guidance.

Shifting from Damage Control to Early Detection

“Cardiology has long focused on treating damage after it occurs,” said Dr. Ashwin B. Mehta, Padma Bhushan awardee and Director of Cardiology at Jaslok Hospital. “With this AI system, we now have the capability to identify at-risk individuals before the onset of disease. This marks a paradigm shift in how we deliver cardiac care.”

The AnginaX AI system analyzes over 20 clinical and lifestyle factors, including advanced lipid panels, blood sugar levels, inflammatory markers, metabolic indicators, family history, and behavioral patterns. Drawing from validated Indian clinical datasets, it generates individualized risk stratification, diagnostic recommendations, and clear treatment and follow-up plans—all in under a minute.

Enabling High-Volume, High-Impact Screening

“In busy OPD environments, speed and precision are critical,” said Dr. Ajit Desai, Senior Cardiologist at Jaslok. “AnginaX enables us to identify silent cardiac risks in real time and guide patients before their first symptom. This enhances efficiency and maximizes impact.”

Recognizing that cost and fear often prevent patients from seeking early screening, Jaslok and AnginaX have ensured that the program is affordable, fast, and user-friendly—bringing preventive care into routine clinical practice.

A Model Built for Real Lives

“This is more than digital innovation—it’s about aligning medical care with timing,” said Mr. Jitendra Haryan, CEO of Jaslok Hospital. “By integrating AI into our OPDs, we are making heart disease prevention accessible and timely—saving lives before the first crisis occurs.

Jaslok has also launched the “Dil Fit, Life Hit” initiative under Dr. Mehta’s leadership, making structured, AI-powered cardiovascular screening a standard part of outpatient care. The program equips doctors with intelligent tools while making preventive care mainstream, not just for the symptomatic or high-risk.

Building for Scale and Impact

“AnginaX was built with one question in mind—Would I trust this system with my own mother’s life?,” said Naman Gosalia, Founder of AnginaX AI. “We tested it on my mother first, and only moved forward when it worked. That conviction drives our mission—to bring primary cardiac prevention to every corner of India without disrupting how doctors practice.”

“Launching with Jaslok, and being the first in Maharashtra, reflects a shared commitment to patient-first innovation. Prevention shouldn’t come with friction, fear, or financial barriers. This partnership is about making better outcomes possible for all.”

Dr. Neeraj Desai, Strategic Medical Advisor to AnginaX AI, added, “AnginaX bridges the gap between data and decision, between missed opportunities and timely care. In medicine, timing is everything—and this is the first time we are putting it in favor of prevention.

AI-based cardiovascular screening has already commenced at Jaslok, allowing doctors to take swift, informed preventive action—especially for patients who may otherwise go undiagnosed until it's too late. This model not only enhances clinical productivity but also redefines India’s approach to tackling its leading cause of death—heart disease.

Related Stories

No stories found.
Voice Of HealthCare
vohnetwork.com